PRF Technologies PRFX
NASDAQ PRFX
$0.93 -0.03 (-3.23%)
At close: Sep 22, 2026 · 4:00 PM EDT

PRF Technologies (PRFX) Net Equity Issued and Repurchased (2020 - 2023)

PRF Technologies' (PRFX) quarterly Net Equity Issued and Repurchased came in at $1.7 million in Q3 2023, up 281.84% quarter-over-quarter from $446000.0 in Q4 2021.

Analysis

PRF Technologies (PRFX) Net Equity Issued and Repurchased (2020 - 2023) Analysis & Trends

PRF Technologies (PRFX) has reported Net Equity Issued and Repurchased for 3 consecutive years, with $1.7 million the latest figure, recorded in Q3 2023.

  • For the quarter ending Q3 2023, Net Equity Issued and Repurchased changed N/A year-over-year to $1.7 million; the trailing twelve-month figure through Dec 2023 stood at $1.7 million (changed N/A YoY), and the FY2025 full-year result was $8000.0, down 99.8% from the prior year.
  • Net Equity Issued and Repurchased improved to $1.7 million in Q3 2023 per PRFX's latest filing, from $446000.0 in the prior quarter.
  • Across five years, Net Equity Issued and Repurchased topped out at $17.3 million in Q3 2020 and bottomed at -$446000.0 in Q3 2021.
  • Historically, Net Equity Issued and Repurchased has averaged $5.0 million across 3 years, with a median of $1.7 million in 2023.
  • The widest YoY moves for Net Equity Issued and Repurchased: up 102.58% in 2021, down 102.58% in 2021.
  • Over 3 years, Net Equity Issued and Repurchased stood at $17.3 million in 2020, then plunged by 97.42% to $446000.0 in 2021, then surged by 281.84% to $1.7 million in 2023.
  • According to Business Quant data, Net Equity Issued and Repurchased over the past three periods registered $1.7 million, $446000.0, and -$446000.0 for Q3 2023, Q4 2021, and Q3 2021 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued (Qtr)
1 Teva Pharmaceutical Industries 46.72 Bn 43.07 Bn 2.15 Bn -
2 Viatris 19.64 Bn 18.75 Bn 1.46 Bn 700,000.00
3 Dr Reddys Laboratories 10.36 Bn 10.22 Bn 396.53 Mn -
4 Amneal Pharmaceuticals 6.44 Bn 6.39 Bn 334.51 Mn -
5 Bausch Health Companies 2.11 Bn 1.24 Bn 2.10 Bn -
6 Ani Pharmaceuticals 1.88 Bn 1.52 Bn 165.89 Mn -
7 Alvotech 1.83 Bn 1.69 Bn 2.56 Mn -
8 Amphastar Pharmaceuticals 1.04 Bn 751.07 Mn 93.47 Mn -
9 Fennec Pharmaceuticals 382.22 Mn 340.97 Mn 17.15 Mn -
10 PRF Technologies 622,054.07 -10.31 Mn - 15.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2023 1.70 Mn
Dec 31, 2021 446,000.00
Sep 30, 2021 -446,000.00
Mar 31, 2021 6.00 Mn
Sep 30, 2020 17.31 Mn
API Access

PRF Technologies Net Equity Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=PRFX&period=max&api_key=YOUR_API_KEY